Despite
growing
interest
in
the
potential
use
of
exogenous
ketones
for
treatment
epilepsy,
their
impact
on
seizures
and
gut
microbiome
mycobiome
remain
unclear.
Frontiers in Cellular Neuroscience,
Год журнала:
2025,
Номер
18
Опубликована: Янв. 8, 2025
The
human
gut
mycobiome,
a
minor
but
integral
component
of
the
microbiome,
has
emerged
as
significant
player
in
host
homeostasis
and
disease
development.
While
bacteria
have
traditionally
been
focus
microbiome
studies,
recent
evidence
suggests
that
fungal
communities
(mycobiota)
may
also
play
crucial
role
modulating
health,
particularly
neuropsychiatric
disorders.
This
review
aims
to
provide
comprehensive
overview
current
knowledge
on
relationship
between
mycobiome
disorders,
exploring
potential
targeting
novel
therapeutic
strategy.
We
summarized
findings
from
metagenomic
analyses
characterize
diversity
composition
mycobiota
discuss
how
these
interact
with
other
microorganisms
via
gut-brain
axis.
Key
methodologies
for
studying
mycobiota,
such
high-throughout
sequencing
bioinformatics
approaches,
were
reviewed
highlight
advances
field.
Emerging
research
links
dysbiosis
conditions
schizophrenia,
Alzheimer's
disease,
autism
spectrum
bipolar
disorder,
depression.
Studies
indicate
specific
populations,
Candida
Saccharomyces,
influence
neuroinflammation,
permeability
immune
responses,
thereby
affecting
mental
health
outcomes.
Understanding
mycobiome's
disorders
opens
new
avenues
interventions,
including
antifungal
treatments,
probiotics,
dietary
modifications.
Future
should
integrate
multi-omics
approaches
unravel
complex
interkingdom
interactions
within
ecosystem,
paving
way
personalized
medicine
care.
Expert Review of Molecular Diagnostics,
Год журнала:
2024,
Номер
24(4), С. 259 - 271
Опубликована: Март 20, 2024
Attention-deficit/hyperactivity
disorder
(ADHD)
is
one
of
the
most
common
neurodevelopmental
conditions
and
highly
heterogeneous
in
terms
symptom
profile,
associated
cognitive
deficits,
comorbidities,
outcomes.
Heterogeneity
may
also
affect
ability
to
recognize
diagnose
this
condition.
The
diagnosis
ADHD
primarily
clinical
but
there
are
increasing
research
efforts
aiming
at
identifying
biomarkers
that
can
aid
diagnosis.
Journal of Fungi,
Год журнала:
2024,
Номер
10(3), С. 192 - 192
Опубликована: Март 1, 2024
This
review
explores
the
‘gut–lung
axis’
in
asthma
with
a
focus
on
commensal
fungal
organisms.
We
explore
how
changes
to
intestinal
community
composition
alter
lung
immune
function.
comprehensively
available
studies
that
have
profiled
of
gut
mycobiome
adults
and
children
asthma,
discuss
mechanisms
gut–lung
interactions
been
described
animal
models
asthma.
Studies
indicate
dysbiosis,
such
as
an
increased
abundance
certain
fungi
like
Candida,
can
elevate
risk
exacerbate
it
adults.
effect
is
mediated
through
various
pathways:
host
system’s
sensing
dysbiosis
via
C-type
lectin
receptors
(e.g.,
Dectin-2),
impact
pro-inflammatory
metabolites
12,13-diHOME,
prostaglandin
E2),
role
cells
group
2
innate
lymphoid
[ILC2],
M2
macrophages).
also
describe
strategies
for
modulating
potential
therapies
severe
The
concludes
by
emphasizing
necessity
further
research
into
deepen
our
understanding
these
complex
interactions.
Nutrients,
Год журнала:
2024,
Номер
16(14), С. 2260 - 2260
Опубликована: Июль 13, 2024
We
conducted
a
12-week
randomized
double-blind
placebo-controlled
clinical
trial
to
investigate
the
potential
impact
of
Bifidobacterium
bifidum
(Bf-688)
supplementation
on
attention-deficit/hyperactivity
disorder
(ADHD).
Children
with
ADHD
who
were
already
receiving
stable
dose
methylphenidate
(MPH)
treatment
enrolled
and
randomly
assigned
two
groups:
one
add-on
Bf-688
(daily
bacterial
count
5
×
109
CFUs)
(n
=
51)
other
placebo
51).
All
participants
underwent
assessments
using
Conners’
Continuous
Performance
Test
(CPT)
Auditory
Attention
(CATA).
Additionally,
fecal
samples
collected
at
beginning
(week
0)
endpoint
12).
Remarkably,
group
supplementation,
but
not
group,
exhibited
significant
improvements
in
omission
errors
CPT
as
well
Hit
reaction
time
both
CATA.
Gut
microbiome
analysis
revealed
increase
Firmicutes
Bacteroidetes
ratio
(F/B
ratio)
only
group.
Furthermore,
we
identified
negative
correlations
between
N-Glycan
biosynthesis
Our
results
demonstrate
that
probiotic
supplement
can
enhance
neuropsychological
performance
children
ADHD,
possibly
by
altering
composition
gut
microbiota,
ultimately
leading
reduced
biosynthesis.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Сен. 13, 2024
Major
depressive
disorder
is
a
condition
involving
microbiota-gut-brain
axis
dysfunction.
Increasing
research
aims
to
improve
depression
through
gut
microbiota
regulation,
including
interventions
such
as
probiotics,
prebiotics,
and
fecal
transplants.
However,
most
focuses
on
exogenous
induced
by
chronic
stress
or
drugs,
with
less
attention
given
endogenous
depression.
Additionally,
mycobiota
in
significantly
than
that
bacteria.
The Kaohsiung Journal of Medical Sciences,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 7, 2025
Attention-deficit/hyperactivity
disorder
(ADHD)
is
a
common
psychiatric
condition
among
children
and
adolescents,
often
associated
with
high
risk
of
comorbidities.
Currently,
ADHD
diagnosis
relies
exclusively
on
clinical
presentation
patient
history,
underscoring
the
need
for
clinically
relevant,
reliable,
objective
biomarkers.
Such
biomarkers
may
enable
earlier
lead
to
improved
treatment
outcomes.
Our
research
team
has
focused
identifying
potential
by
investigating
its
possible
pathomechanisms,
consideration
aforementioned
criteria.
Given
significant
sex-related
differences
in
prevalence
(male
predominance)
age-related
variability
symptomatology,
we
explored
role
neuroendocrine
systems
ADHD.
Specifically,
examined
epigenetic
regulation
mechanism
involved
pathogenesis
developed
diagnostic
model
based
peripheral
microRNA.
Additionally,
investigated
microbiota
dysbiosis
pathophysiology
provided
novel
insights
into
management.
This
paper
presents
summary
our
findings
By
analyzing
blood,
salivary,
fecal
samples,
identified
several
promising
that
serve
as
parameters
improving
accuracy
Further
involving
larger
cohort
studies
required
confirm
reliability
these
Frontiers in Microbiology,
Год журнала:
2025,
Номер
16
Опубликована: Янв. 29, 2025
Attention
Deficit
Hyperactivity
Disorder
(ADHD)
is
a
clinically
common
neurodevelopmental
disorder
of
the
brain.
In
addition
to
genetic
factors,
an
imbalance
in
gut
flora
may
also
play
role
development
ADHD.
Currently,
it
critical
investigate
function
and
related
metabolites,
which
form
fundamental
basis
bidirectional
cross-linking
between
brain
gut,
focusing
on
changed
This
study
aimed
possible
relationship
changes
metabolites
ADHD
by
analyzing
metagenome
untargeted
metabolomics
fecal
samples
from
patients.
Specifically,
we
attempted
identify
key
metabolic
pathways
they
are
involved
in,
as
well
analyze
detail
structure
composition
order
further
symptoms,
some
behavioral
studies
were
conducted
following
transplantation
patients
into
rats.
The
results
analysis
revealed
several
distinct
strains,
including
Bacteroides
cellulosilyticus
,
could
be
important
for
diagnosing
Additionally,
group
showed
modifications
nicotinamide
nicotinic
acid
metabolite
this
pathway.
demonstrated
that
rats
with
transplants
displayed
increased
locomotor
activity
interest,
indicating
onset
behaviors
such
facilitated
associated
research
verified
alterations
metabolism
observed
provided
list
significantly
altered
Simultaneously,
our
findings
microbiome
potentially
trigger
animals,
providing
experimental
comprehending
influence
These
might
provide
new
perspectives
novel
treatment
strategies.
Journal of Fungi,
Год журнала:
2025,
Номер
11(4), С. 279 - 279
Опубликована: Апрель 2, 2025
The
human
gastrointestinal
tract
harbors
a
vast
array
of
microorganisms,
which
play
essential
roles
in
maintaining
metabolic
balance
and
immune
function.
While
bacteria
dominate
the
gut
microbiome,
fungi
represent
much
smaller,
often
overlooked
fraction.
Despite
their
relatively
low
abundance,
may
significantly
influence
both
health
disease.
Advances
next-generation
sequencing,
metagenomics,
metatranscriptomics,
metaproteomics,
metabolomics,
computational
biology
have
provided
novel
opportunities
to
study
mycobiome,
shedding
light
on
its
composition,
functional
genes,
metabolite
interactions.
Emerging
evidence
links
fungal
dysbiosis
various
diseases,
including
inflammatory
bowel
disease,
colorectal
cancer,
disorders,
neurological
conditions.
mycobiome
also
presents
promising
avenue
for
precision
medicine,
particularly
biomarker
discovery,
disease
diagnostics,
targeted
therapeutics.
Nonetheless,
significant
challenges
remain
effectively
integrating
knowledge
into
clinical
practice.
This
review
examines
microbiota,
highlighting
analytical
methods,
associations
with
potential
role
medicine.
It
discusses
pathways
translation,
diagnosis
treatment,
while
addressing
key
barriers
implementation.